In the current investigation, we have adapted response surface methodology (RSM) and artificial neural network-genetic algorithm (ANN-GA) based optimization to develop a defined medium for maximizing human interferon gamma production from recombinant Kluyveromyces lactis (K. lactis).In the initial screening studies, sorbitol and glycine emerged as a carbon and nitrogen source respectively having higher influence on hIFN-g production. Substrate inhibition studies were performed by varying the initial substrate concentration, and we found maximum hIFN-g concentration at 50 g L À1 of sorbitol. Inhibition kinetics studies were carried out using 3 and 4-parametric models. Among the estimated models, the Moser model was observed as the best fitted model followed by the Luong model with R 2 values of 0.882 and 0.75, respectively. The model acceptability test was carried out using the extra sum of squares F-test and Akaike information criterion (AIC). The Plackett-Burman multifactorial design identified sorbitol, glycine, Na 2 HPO 4 , and MgSO 4 .7H 2 O as the parameters significantly influencing the hIFN-g production. Further, the Box-Behnken design (BBD) followed by the artificial neural network coupled with genetic algorithm (ANN-GA) was employed for the precise optimization of medium components. With ANN-GA a maximum hIFN-g yield of 2.1 AE0.3 mg L À1 in shake flask level and 3.5 AE0.1 mg L À1 in reactor level was achieved. The findings of this study serve as a model for a process development strategy (bench scale to reactor scale) to achieve a high productivity of the desired protein from a microbial cell factory.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.